
Souvenaid is clinically proven to improve memory in early Alzheimer’s disease patients in double blind, randomized, controlled trials.
Read MoreThe unique, patented combination of nutrients supports phospholipid synthesis which is a key component in the process of neuronal membrane formation
Read MoreSouvenaid is a medical nutrition product for the dietary management of early Alzheimer’s disease, available as a convenient once-daily drink
Read MoreMedical nutrition provides patients with nutritional support for the management of a specific disease or medical condition.
Read MoreSpecific nutrients are required to counter the effects of synapse loss in Alzheimer’s disease.
Read MoreSynapse formation is dependent on the presence of key nutrients required for phospholipid synthesis.
Read More